Treatment of Typhoid Fever (S. Typhi Infection)
Since you were asking in the context of an IgM-positive Typhidot (suggesting acute typhoid), here's how it's managed:
1. General measures
- Hospitalization for moderate-to-severe cases; oral rehydration/IV fluids, antipyretics, and a soft, nutritious diet.
- Isolation of confirmed cases is advised until three bacteriologically negative stool and urine samples are obtained on separate days, since stool/urine are the main sources of spread - Park's Textbook of Preventive and Social Medicine, p. 278.
2. Antibiotic therapy (mainstay)
Choice depends on local resistance patterns of S. Typhi:
| Susceptibility | First-line | Alternative |
|---|
| Fully sensitive | Fluoroquinolone (ciprofloxacin/ofloxacin) 15 mg/kg/day x 5-7 days | Chloramphenicol, amoxicillin, or TMP-SMX x 14-21 days |
| Multidrug-resistant (MDR) | Fluoroquinolone or cefixime 15-20 mg/kg/day x 7-14 days | Azithromycin 8-10 mg/kg/day x 7 days |
| Quinolone-resistant | Azithromycin (8-10 mg/kg/day x 7 days) or ceftriaxone (75 mg/kg/day x 10-14 days) | Cefixime 20 mg/kg/day x 7-14 days |
- Park's Textbook of Preventive and Social Medicine, p. 279
In practice today: fluoroquinolone resistance is now widespread in South Asia, so ceftriaxone (IV) or oral azithromycin are the preferred first-line agents in most endemic regions, with oral cefixime as another option - Harrison's Principles of Internal Medicine, 22nd Ed.; Tintinalli's Emergency Medicine.
A 2022 systematic review of 27 RCTs found no significant difference in treatment failure, relapse, or adverse events between ceftriaxone, fluoroquinolones, and azithromycin, supporting flexible first-line choice based on local resistance - Harrison's Principles of Internal Medicine, 22nd Ed.
Extensively drug-resistant (XDR) strains (resistant to ceftriaxone, ampicillin, ciprofloxacin, and TMP-SMX) have emerged, notably in Pakistan - these remain susceptible mainly to azithromycin and carbapenems - Red Book 2021, Committee on Infectious Diseases.
3. Severe/toxic typhoid
For seriously ill, profoundly toxic patients (e.g., delirium, shock, obtundation), IV dexamethasone or hydrocortisone (e.g., hydrocortisone 100 mg/day for 3-4 days) is added alongside antibiotics to reduce mortality - Park's Textbook of Preventive and Social Medicine, p. 278.
4. Complications requiring surgery
Intestinal (ileal) perforation is the most feared complication:
- Manage in intensive care with resuscitation and IV antibiotics
- Laparotomy is required (commonest site: terminal ileum)
- Always inspect for additional perforations
- In critically ill patients, consider exteriorization; the abdominal wound may be left open for delayed secondary closure
- Bailey and Love's Short Practice of Surgery, 28th Ed.
5. Chronic carrier state (Vi antigen positive, ~1-4% of cases)
- High-dose ampicillin or amoxicillin (4-6 g/day) plus probenecid (2 g/day) for 6 weeks - achieves eradication in ~70% of carriers (chloramphenicol is ineffective for this).
- Cholecystectomy with concurrent ampicillin for gallbladder carriers refractory to antibiotics (cure rate up to ~80%).
- Urinary carriers with a damaged kidney occasionally need nephrectomy.
- Park's Textbook of Preventive and Social Medicine, p. 279
6. Prevention/adjunct
Typhoid conjugate vaccines (Typbar TCV, TYPHIBEV) are WHO-recommended for high-incidence countries and reduce future risk, but are not a treatment for active infection.
Evidence check: A recent systematic review (Uzair et al., 2024, PMID: 39623850) comparing oral azithromycin against other antimicrobials across all age groups found azithromycin comparably effective to ceftriaxone/fluoroquinolones with a favorable safety profile, consistent with the textbook guidance above. No major contradictions were found versus current textbook recommendations.
If you can share the patient's clinical severity (uncomplicated vs. toxic/complicated), age, and local resistance data (if known), I can help narrow down the specific regimen.